05 Oct 2026

Sweden brought revised maximum-price rules for interchangeable medicines into force on 1 October 2026. The Dental and Pharmaceutical Benefits Agency (Tandvårds- och läkemedelsförmånsverket, TLV) introduced a separate pricing regulation for medicines in its monthly generic-substitution system, replacing the previous framework.

Under the former rules, TLV generally set a ceiling at 35% of the price prevailing when generic competition began, once price reductions and a minimum period of competition met specified conditions. The revised rules introduce potential ceiling levels of 70%, 35% and 20% of the initial ceiling, conditional on sustained lower market prices.

The 70% and 35% levels require the monthly designated lowest-priced medicine to be priced below 50% or 25% of the initial ceiling, respectively, in at least three of six consecutive monthly periods. The 20% level requires prices below 5% over the same period and at least six months since the 35% ceiling took effect. This deepest reduction applies only to the qualifying pack-size group.

The minimum permitted ceiling rises from SEK 15 to SEK 30 per pack, with inflation adjustment from 2028. TLV may also approve price increases above an existing ceiling, including temporary increases where critical shortages threaten availability. Qualifying ceilings may receive inflation adjustments from 2027.

The new rules did not automatically change existing medicine prices on 1 October. Only ceilings previously below SEK 30 were raised at commencement. The first new reductions in ceilings may take effect in January 2027, affecting medicine prices from February.

The framework links further generic price reductions to observed competition while allowing targeted increases where low prices could undermine continued supply.

Source: Dental and Pharmaceutical Benefits Agency, TLV
Link: Nytt takprisregelverk från 1 oktober (New price-ceiling framework from 1 October)
Date: 10 June 2026

Source: Dental and Pharmaceutical Benefits Agency, TLV
Link: Tandvårds- och läkemedelsförmånsverkets föreskrifter om prissättning av utbytbara läkemedel (Regulations on pricing interchangeable medicines)
Date: 1 June 2026